I Sundström

Summary

Country: Sweden

Publications

  1. ncbi Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects
    I Sundström
    Department of Obstetrics and Gynecology, University Hospital of Umea, Sweden
    Neuroendocrinology 67:126-38. 1998
  2. ncbi Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial
    I Sundström
    Department of Obstetrics and Gynecology, University Hospital of Umea, Sweden
    Psychoneuroendocrinology 23:73-88. 1998
  3. ncbi Lack of influence of menstrual cycle and premenstrual syndrome diagnosis on pregnanolone pharmacokinetics
    I Sundström
    Department of Obstetrics and Gynaecology, University Hospital of Umea, Sweden
    Eur J Clin Pharmacol 55:125-30. 1999

Collaborators

Detail Information

Publications3

  1. ncbi Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects
    I Sundström
    Department of Obstetrics and Gynecology, University Hospital of Umea, Sweden
    Neuroendocrinology 67:126-38. 1998
    ..These findings are compatible with a decreased GABAA-receptor sensitivity in brain areas controlling saccadic eye movements among PMS patients in the late luteal phase...
  2. ncbi Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial
    I Sundström
    Department of Obstetrics and Gynecology, University Hospital of Umea, Sweden
    Psychoneuroendocrinology 23:73-88. 1998
    ..These findings indicate that treatment with a selective serotonin reuptake inhibitor in the luteal phase increases the pregnanolone sensitivity in patients with premenstrual syndrome...
  3. ncbi Lack of influence of menstrual cycle and premenstrual syndrome diagnosis on pregnanolone pharmacokinetics
    I Sundström
    Department of Obstetrics and Gynaecology, University Hospital of Umea, Sweden
    Eur J Clin Pharmacol 55:125-30. 1999
    ..This study was undertaken to determine whether hormonal changes during the menstrual cycle influence pregnanolone pharmacokinetics and to compare PMS diagnosis-related differences in pregnanolone pharmacokinetics...